In a substudy of 178 patients from the SUSTAIN 8 trial on semaglutide as a diabetes treatment, the average proportion of lean mass loss was nearly identical at 40%, despite lower doses and less total weight loss than in the STEP 1 trial
[1] [2] If you are pregnant, think you might be pregnant, or are planning to have a baby, seek immediate advice from your healthcare provider about alternative diabetes management strategies
To include patients with liver diseases irrespective of etiology, we searched for the following search terms in the titles, abstracts, and keywords: hepatic encephalopathy, liver encephalopathy, Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Alcoholic Fatty Liver, Hepatitis, Human Viral Hepatitides, Liver Cirrhosis, Hepatic Cirrhosis, Liver Fibroses, Liver Fibrosis, Liver Neoplasm, Hepatic Neoplasms, Cancer of Liver, Hepatocellular Cancer, and liver disease in combination with levocarnitine, Vitamin BT, L-carnitine, L carnitine, and carnitine
G.DrummondG
